β-Polydextrose Compound Capsules
The β-polydextrose composite capsule addresses the challenges of absorption and stability in existing products by using a dual-shell design to securely store the immune-regulating contents, enhancing both stability and immune function.
Patent Information
- Application Number
- JP2025000590U
- Authority / Receiving Office
- JP · JP
- Patent Type
- Utility models
- Current Assignee / Owner
- Filing Date
- 2025-02-25
- Publication Date
- 2025-04-25
- Estimated Expiration
- 2035-02-25
AI Technical Summary
Existing β-polyglucose products face challenges with absorption and stability, and their health benefits can be improved. Additionally, existing capsule designs are difficult to assemble and tend to be unstable, increasing the risk of them falling.
The β-polydextrose composite capsule features a dual-shell design with a first capsule shell and a transparent second capsule shell. The shells are designed to fit together securely, forming a sealed storage space for the contents, which include β-polydextrose, glutamic acid, paracathelial lactic acid bacteria, zinc glycinate, selenium yeast, magnesium stearate, and silicon dioxide.
This design ensures complete storage and stability of the contents, simplifies the assembly process, reduces the risk of the capsules falling, and effectively regulates immune function, making it a stable and effective health supplement.
Smart Images

Figure 0003251080000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a capsule structure, and in particular to a beta-polydextrose composite capsule. [Background technology]
[0002] Immunity is the ability of the human body to prevent disease, and it is the immune system that is responsible for this important function. The human immune system has three main functions. First, immune defense: When pathogenic microorganisms invade the human body, the immune system can recognize and resist these foreign pathogenic substances to maintain health. Second, immune surveillance: The immune system can recognize and eliminate mutant cells in the body in a timely manner, reducing the risk of growth and tumor formation. Third, immune stability: The immune system can eliminate self-metabolites in a timely manner to prevent autoimmune diseases caused by their accumulation. From these three functions, we can see that the human immune system is an important line of defense for maintaining health, and a weakened immune system directly reflects the susceptibility to disease. Therefore, enhancing immunity and ensuring the proper functioning of the immune system is key to maintaining health. When a pathogen invades, a strong immune system can activate the "self-healing power of the human body" to effectively eliminate the pathogen and promote the recovery of the human body.
[0003] The immune system of the human body is a complex ecosystem. Under normal circumstances, the immune system can self-regulate, resist infection by external pathogens, eliminate cancer cells, and prevent the occurrence of autoimmune diseases by eliminating reactive lymphocytes in a timely manner. However, immune dysfunction can lead to various diseases, such as autoimmune diseases, immunodeficiency diseases, infections, and tumors. Immune compromise is one of the important contributing factors in the pathogenesis of infections and tumors.
[0004] According to the World Health Organization (WHO), approximately 50% of the world's population is immunocompromised, making it urgent to improve immunity. As economic globalization accelerates and people's lifestyles become more rapid, factors such as long-term fatigue, increased psychological pressure, and irregular lifestyles lead to an increase in the number of people with immunocompromised immunity year by year. Therefore, strengthening the human immune system has become one of the most important issues that require particular attention in modern society.
[0005] Beta-glucan is a natural polysaccharide substance found widely in grains, yeast and some fungi. Research has shown that it has various biological activities and can effectively regulate immune function. However, the beta-glucose products on the market still have deficiencies in absorption rate and stability, and its health benefits need to be further improved. In addition, the capsules of existing products are not only difficult to assemble, but also prone to unstable fastening structures, which increases the possibility of them falling off. Summary of the Invention [Problem to be solved by the invention]
[0006] In consideration of the above problems that we are trying to solve, we came up with this idea, and after going through many discussions, prototyping, and making many modifications and improvements, we would like to propose this idea. [Means for solving the problem]
[0007] The β-polydextrose composite capsule of the present invention comprises a capsule body and a content, the capsule body having a first capsule shell and a second capsule shell, one end of the first capsule shell is provided with a first opening, the other end of the first capsule shell is provided with a first circular-arc-shaped sealed end, the outer edge of the first capsule shell is provided with a first fastening mechanism, the second capsule shell is transparent, one end of the second capsule shell is provided with a second opening, the other end of the second capsule shell is provided with a second circular-arc-shaped sealed end, the inner edge of the second capsule shell is provided with a second fastening mechanism, the first opening of the first capsule shell and the second opening of the second capsule shell are fitted together, the first fastening mechanism and the first fastening mechanism are fastened together to form a sealed storage space, the content is contained in the storage space, and the ingredients of the content include β-polydextrose, glutamic acid, Lactobacillus paracasei, zinc glycinate, selenium yeast, magnesium stearate and silicon dioxide. Effect of the Invention
[0008] The β-polydextrose composite capsule of the present invention has a first capsule shell and a second capsule shell that are tightly bonded together, and the contents are completely stored inside the capsule body. The second capsule shell is then installed transparently, making it easy to visually check the fastening state between the first fastening structure and the first fastening structure, simplifying the assembly process and reducing the possibility of it falling off, ensuring the stability and effectiveness of the contents, and also aiming at the compound prescription of the contents effectively regulating immune function. [Brief description of the drawings]
[0009] [Figure 1] FIG. 1 is a three-dimensional view of the present invention. [Diagram 2] FIG. 2 is an exploded view of the present invention. [Diagram 3] FIG. 3 is an exploded plan view of the present invention. [Figure 4] FIG. 4 is a cross-sectional view of the first and second capsule shells. [Diagram 5]FIG. 5 is a plan view of the present invention. [Figure 6] FIG. 6 is a cross-sectional view taken along line A-A in FIG. [Figure 7] FIG. 7 is an enlarged view of part A1 in FIG. Form for implementing a utility model
[0010] We will now further describe the present invention in conjunction with the drawings of preferred embodiments of the present invention so that those skilled in the art can implement the present invention according to the description in this specification.
[0011] First, please refer to Figures 1 to 7. The β-polydextrose composite capsule of the present invention comprises a capsule body 10 and a content 20.
[0012] The capsule body 10 has a first capsule shell 11 and a second capsule shell 12 .
[0013] The first capsule shell 11 is made of an edible material. The cross section of the first capsule shell 11 is circular, one end of the first capsule shell 11 is provided with a first opening 111, the other end of the first capsule shell 11 is provided with a first closed end 112 in the shape of a circular arc, the outer edge of the first capsule shell 111 is provided with a first fastening structure, and the first opening 111 has an outer diameter D1. In this embodiment, the first fastening structure is an annular recess 113, which is close to the first opening 111, and the cross section of the annular recess 113 is in the shape of a concave arc.
[0014] The second capsule shell 12 is made of edible material and is transparent. The cross section of the second capsule shell 12 is circular, one end of the second capsule shell 12 is provided with a second opening 121, the other end of the second capsule shell 12 is provided with a second closed end 122 in the shape of a circular arc, the outer edge of the second opening 121 is provided with a second fastening structure, and the second opening 121 has an inner diameter D2. The inner diameter D2 of the second opening 121 is approximately equal to the outer diameter D1 of the first capsule shell 111. In this embodiment, the second fastening structure is an annular protrusion 123, which is located in the middle of the second capsule shell 12, and the cross section of the annular protrusion 123 is in the shape of a convex arc.
[0015] The first opening 111 of the first capsule shell 11 and the second opening 121 of the second capsule shell 12 fit together, and the annular recess 113 of the first capsule shell 11 and the annular protrusion 123 of the second capsule shell 12 engage with each other to form a tight bond, thereby forming a receiving space 13 between the first capsule shell 11 and the second capsule shell 12. Then, by fitting the two together, it is convenient to visually check the engagement state between the annular recess 113 and the annular protrusion 123 through the second capsule shell 12.
[0016] The contents 20 are in a powder form and are placed in the receiving space 13. The components of the contents 20 include β-polydextrose 21, glutamic acid 22, Lactobacillus paracasei 23, zinc glycinate 24, selenium yeast 25, magnesium stearate 26, and silicon dioxide 27. β-polydextrose 21 is a main component that plays a role in strengthening the immune system, glutamic acid 22 helps repair and regenerate cells to strengthen immune function, Lactobacillus paracasei 23 is a probiotic component that promotes intestinal health, zinc glycinate 24 helps improve immune system function, selenium yeast 25 is rich in selenium and is useful for antioxidant and immune regulation, magnesium stearate 26 is an anti-lump agent that plays a role in ensuring the fluidity of the contents, and silicon dioxide 27 is used to increase the stability and fluidity of the capsule.
[0017] When taking beta-polydextrose complex capsules, consumers can adjust the dosage according to their health condition and doctor's advice. The recommended dosage for adults is usually two capsules taken daily after meals, by opening the capsule and soaking the powder in water or adding milk.
[0018] Due to the structure of the above specific embodiment, the following beneficial effects may be obtained.
[0019] In the beta-polydextrose composite capsule of the present invention, the first capsule shell 11 is tightly combined with the second capsule shell 12 to ensure the complete preservation of the contents 20, and the second capsule shell 12 is transparent, which is convenient for the user to visually inspect and easily check the fastening state between the first fastening structure and the second fastening structure, which not only simplifies the assembly process but also significantly reduces the possibility of falling off, ensuring the stability and effectiveness of the contents 20. Moreover, the contents 20 of the composite capsule can effectively regulate the immune function by carefully formulating the formula. Due to the above functions, the composite capsule is an ideal health supplement product, especially suitable for people who need to improve their immune system and metabolism. [Explanation of symbols]
[0020] 10-capsule body;11-first capsule shell;111-first opening;112-first closed end;113-annular recess;12-second capsule shell;121-second opening;122-second closed end;123-annular protrusion;13-container space;20-contents;21-β-polydextrose;22-glutamic acid;23-Lactobacillus paracasei;24-zinc glycinate;25-selenium yeast;26-magnesium stearate;27-silicon dioxide;D1-outer diameter;D2-inner diameter
Claims
1. a capsule body and a content, the capsule body having a first capsule shell and a second capsule shell, a first opening at one end of the first capsule shell, a first closed end in an arc shape at the other end of the first capsule shell, a first fastening mechanism at the outer edge of the first capsule shell, the second capsule shell being transparent, a second opening at one end of the second capsule shell, a second closed end in an arc shape at the other end of the second capsule shell, a second fastening mechanism at the inner edge of the second capsule shell, the first opening of the first capsule shell and the second opening of the second capsule shell fitting together, the first fastening mechanism and the first fastening mechanism fastening together to form a sealed storage space; the content is placed in the storage space, and the ingredients of the content include β-polydextrose, glutamic acid, Lactobacillus paracasei, zinc glycinate, selenium yeast, magnesium stearate, and silicon dioxide; A β-polydextrose composite capsule.
2. The first fastening structure is an annular recess, the annular recess is close to the first opening, the second fastening structure has an annular protrusion, the annular protrusion is disposed in the middle of the second capsule shell, and the annular recess of the first capsule shell and the annular protrusion of the second capsule shell are fastened to each other.
2. The β-polydextrose composite capsule according to claim 1.
3. 2. The β-polydextrose composite capsule according to claim 1, wherein the cross section of the first capsule shell and the cross section of the second capsule shell are both circular.
4. a first opening of the first capsule shell having an outer diameter and a second opening of the second capsule shell having an inner diameter, the inner diameter of the second opening being approximately equal to the outer diameter of the first capsule shell; 2. The β-polydextrose composite capsule according to claim 1.
5. 2. The β-polydextrose composite capsule according to claim 1, characterized in that the contents are in powder form.